This protocol is judged by an institutional critique board, an unbiased team that evaluations any medical trials involving people. If a study consists of a Plan I drug, after the board approves the protocol as ethical, the researchers have to apply for an investigational new drug (IND) selection in the FDA.“It’s important to remember that they�